慢性気管支炎(Chronic Bronchitis):世界の治験レビュー2014年下半期版

◆英語タイトル:Chronic Bronchitis Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2481CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年12月22日
◆ページ数:99
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における慢性気管支炎(Chronic Bronchitis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 慢性気管支炎(Chronic Bronchitis)
  - 当レポートの概要
・慢性気管支炎(Chronic Bronchitis):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Chronic Bronchitis Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Chronic Bronchitis Global Clinical Trials Review, H2, 2014″ provides data on the Chronic Bronchitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Bronchitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Bronchitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Chronic Bronchitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chronic Bronchitis to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Chronic Bronchitis to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Chronic Bronchitis 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Chronic Bronchitis Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Bayer AG 31
Clinical Trial Overview of Bayer AG 31
Sanofi 32
Clinical Trial Overview of Sanofi 32
C. H. Boehringer Sohn AG & Co. KG 33
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 33
Zambon Company S.p.A. 34
Clinical Trial Overview of Zambon Company S.p.A. 34
Sumitomo Dainippon Pharma Co., Ltd. 35
Clinical Trial Overview of Sumitomo Dainippon Pharma Co., Ltd. 35
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Abbott Laboratories 39
Clinical Trial Overview of Abbott Laboratories 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Clinical Trial Overview of Top Institutes / Government 41
University of Milan 41
Clinical Trial Overview of University of Milan 41
Royal Brompton & Harefield NHS Foundation Trust 42
Clinical Trial Overview of Royal Brompton & Harefield NHS Foundation Trust 42
University of California, Los Angeles 43
Clinical Trial Overview of University of California, Los Angeles 43
McMaster University 44
Clinical Trial Overview of McMaster University 44
University of Washington 45
Clinical Trial Overview of University of Washington 45
University of Michigan 46
Clinical Trial Overview of University of Michigan 46
University of Glasgow 47
Clinical Trial Overview of University of Glasgow 47
Hospital Universitario Virgen del Rocio 48
Clinical Trial Overview of Hospital Universitario Virgen del Rocio 48
Federal University of Sao Paulo 49
Clinical Trial Overview of Federal University of Sao Paulo 49
University of Miami 50
Clinical Trial Overview of University of Miami 50
Five Key Clinical Profiles 51
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Disclaimer 99
Source 99

List of Tables
Chronic Bronchitis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Chronic Bronchitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Bronchitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Chronic Bronchitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Chronic Bronchitis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Chronic Bronchitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Chronic Bronchitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Chronic Bronchitis to Respiratory Clinical Trials, G7 Countries (%), 2014* 15
Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Chronic Bronchitis to Respiratory Clinical Trials, E7 Countries (%), 2014* 18
Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Chronic Bronchitis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Chronic Bronchitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Chronic Bronchitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Chronic Bronchitis Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Chronic Bronchitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Chronic Bronchitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Chronic Bronchitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Chronic Bronchitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Chronic Bronchitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 31
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 32
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 33
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2014* 34
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sumitomo Dainippon Pharma Co., Ltd., 2014* 35
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 36
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 37
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 39
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 40
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014* 41
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Brompton & Harefield NHS Foundation Trust, 2014* 42
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 43
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2014* 44
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 45
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 46
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Glasgow, 2014* 47
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Virgen del Rocio, 2014* 48
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2014* 49
Chronic Bronchitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 50

List of Figures
Chronic Bronchitis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Chronic Bronchitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Chronic Bronchitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Chronic Bronchitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Chronic Bronchitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Chronic Bronchitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Chronic Bronchitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Chronic Bronchitis to Respiratory Clinical Trials, G7 Countries (%), 2014* 15
Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Chronic Bronchitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Chronic Bronchitis to Respiratory Clinical Trials, E7 Countries (%), 2014* 18
Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Chronic Bronchitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Chronic Bronchitis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Chronic Bronchitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Chronic Bronchitis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Chronic Bronchitis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Chronic Bronchitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Chronic Bronchitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Chronic Bronchitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Chronic Bronchitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Chronic Bronchitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 98

【レポートのキーワード】

慢性気管支炎(Chronic Bronchitis)、治験、臨床試験、治験、治療薬

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[慢性気管支炎(Chronic Bronchitis):世界の治験レビュー2014年下半期版]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆